Head-to-head · Cost-Efficiency Index
Vitara RX vs ShedRx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Vitara RX
Value-first shoppers who want the cheapest all-50 price on both molecules and refuse to trade away pharmacy verification to get it.
Visit Vitara RXShedRx
People who want the cheapest disclosed tirzepatide or an oral option without giving up a modelable flat price.
Visit ShedRxThe verdict
Vitara RX and ShedRx tie on the Cost-Efficiency Index at 87/100, so neither wins outright on the numbers. For most shoppers we'd start with Vitara RX (ranked #5, a hair above #9) — Value-first shoppers who want the cheapest all-50 price on both molecules and refuse to trade away pharmacy verification to get it. But ShedRx is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Vitara RX.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Vitara RX | ShedRx |
|---|---|---|
| Cost-Efficiency Index | 87/100 | 87/100 |
| Semaglutide / mo | $99/mo | $199/mo |
| Tirzepatide / mo | $149/mo | $299/mo |
| Semaglutide / yr (modeled) | $1,188 | $2,388 |
| Tirzepatide / yr (modeled) | $1,788 | $3,588 |
| Coverage | All 50 states | Not disclosed |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank on the board | #5 | #9 |
Vitara RX
87/100Where the value is
- $99 semaglutide and $149 tirzepatide — among the lowest combined prices on the board, and cheaper on tirzepatide than most sub-$100-sema rivals
- Nationwide all-50 access with both molecules disclosed for clean year-one cost modeling
- LegitScript-certified — budget pricing without the unverified-pharmacy asterisk that dogs the cheapest tier
The tradeoffs
- Compounded only — no FDA-approved brand-name or oral/sublingual route
- Lower-profile newcomer without a long public track record
ShedRx
87/100Where the value is
- Lowest published tirzepatide price of our partner tier at $299/mo
- Offers oral/sublingual forms — more formulation options per dollar
- Both molecules disclosed for straightforward cost comparison
The tradeoffs
- States-served not disclosed
- Compounded only
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.